## EFX: Equifax Inc. - XLI: Industrials

### Executive Summary

VALUE thesis: PEG 1.01 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($210.42)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Equifax, Inc. $EFX Position Lessened by Texas Permanent School Fund Corp**
- Source: MarketBeat | 20251221T102153 | Neutral | Relevance: 100%
- Texas Permanent School Fund Corp significantly reduced its stake in Equifax, Inc. by 34.1% in the second quarter, selling 5,345 shares and leaving 10,340 shares valued at approximately $2.68 million. Company insiders have also been net sellers, with key executives selling over 54,000 shares worth about $12.58 million. Despite this, Equifax recently surpassed quarterly earnings estimates, provided optimistic guidance for Q4 2025 and FY2025, and maintains an average analyst rating of "Moderate Buy" with a target price of $274.73.

**2. Form DEF 14A BEAZER HOMES USA INC For: Sep 30**
- Source: StreetInsider | 20251222T131029 | Neutral | Relevance: 59%
- BEAZER HOMES USA INC. has filed its DEF 14A form for the period ending September 30, detailing proposals for the upcoming annual meeting on February 5, 2026. Key proposals include the election of directors, an advisory vote on executive compensation, ratification of Deloitte & Touche LLP as independent auditors, and the adoption and ratification of protective measures related to NOLs and Energy-Efficiency Tax Credits. The company also reported its financial and operational achievements for fiscal year 2025, highlighting its continued progress towards multi-year goals, including increased community count and achieving its Zero Energy Ready home goal.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $280 | $290 | -3% |
| 2025-12-08 | BMO Capital | $234 | $245 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Overweight |
| 2025-12-08 | BMO Capital | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.90M) |
| Sells | 5 ($1.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+2.1%)
- Capital Internationa: 8.5% (-0.4%)
- Blackrock Inc.: 7.5% (+1.4%)
- Price (T.Rowe) Assoc: 4.9% (+1.0%)
- Harris Associates L.: 4.8% (+14.2%)

### Key Risks

1. Long-term trend broken: trading 8.9% below SMA200.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.01 suggests fair value with growth premium. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.2B |
| Beta | 1.59 |
| 52W Range | $199.98 - $281.07 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.01 |
| Forward P/E | 25.0 |
| Current P/E | 29.0 |
| YoY Growth | 16.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-1.0% over 5 days). Below STRENGTH zone by 1.8pp (needs >4.0% for momentum thesis). MRS_5 (-0.8%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.91x), long-term trend not supportive. MACD histogram positive (1.21), confirming momentum. RSI neutral at 59. OFD pattern: +DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.21% (CS: 68) | Neutral |
| RSI_14 | 58.8 | Neutral |
| MACD Histogram | 1.21 | Bullish |
| vs SMA20 | 1.028x | Above |
| vs SMA50 | 1.022x | Above |
| vs SMA200 | 0.911x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $220.46
- **Stop Loss:** $210.42 (4.6% risk)
- **Target:** $240.54 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 89
- **Position Value:** $19,620.94
- **Portfolio %:** 19.62%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-05 (Est: $2.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.94 | $2.04 | +5.3% |
| 2025Q2 | $1.92 | $2.00 | +4.1% |
| 2025Q1 | $1.40 | $1.53 | +9.0% |
| 2024Q4 | $2.10 | $2.12 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*